John L Lamattina
Director · 3 filings · Latest: Jun 10, 2026
LIGAND PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LGND | John L Lamattina | Director | Jun 10, 2026 | Sale | $250.88 | 4,591 | $1.2M | 26,969 | |
LGND | JOHN L LAMATTINA | — | Jun 10, 2026 | Proposed Sale | $250.88 | 4,519 | $1.1M | — | |
LGND | John L Lamattina | Director | Mar 6, 2026 | Sale | $200.76 | 2,161 | $433.8K | 30,724 | |
LGND | John L Lamattina | Director | Mar 6, 2026 | Option Exercise | $114.15 | 2,161 | $246.7K | 32,885 | |
LGND | JOHN L LAMATTINA | — | Mar 6, 2026 | Proposed Sale | $200.76 | 2,161 | $433.8K | — | |
LGND | JOHN L LAMATTINA | — | Nov 7, 2025 | Proposed Sale | $205.45 | 4,179 | $858.6K | — | |
LGND | LAMATTINA JOHN L | — | Nov 26, 2024 | Proposed Sale | $119.19 | 2,406 | $286.8K | — |